Medical and Scientific: SA leads the way in brain cancer trials

04 Feb 2021 - Medical and Scientific

Human clinical trials for a world-first drug candidate to treat the most aggressive form of brain cancer are set to get under way this year. Researchers from the University of South Australia developed the new drug, called Auceliciclib, to treat glioblastoma, a rare cancer that kills 95 per cent of patients within five years. There is currently no cure, but initial results from animal trials of Auceliciclib suggest it could offer a new treatment for humans. Trials of the drug in cancer patients will begin in April and will be conducted by Adelaide-based biotech company Aucentra Therapeutics. The drug will first be tested in patients from Adelaide and then later used in clinical trial centres around the country.

Adelaide Advertiser; 04/02/2021; Page 25